Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Snaith

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Clinical and Experimental Rheumatology|September 1, 1992
Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLEC Vitali, W Bencivelli, D A Isenberg, et al.
Clinical and Experimental Rheumatology|September 1, 1992
Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLEC Vitali, W Bencivelli, D A Isenberg, et al.
British Journal of Rheumatology|June 1, 1988
Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogueD A Yardumian, D A Isenberg, M Rustin, et al.
International Journal of Immunopharmacology|January 1, 1981
Cyclosporin A for the treatment of systemic lupus erythematosusD A Isenberg, M L Snaith, W J Morrow, et al.
The New England Journal of Medicine|September 25, 1980
Cyclosporin relieves arthralgia, causes angioedemaD A Isenberg, M L Snaith, A A Al-Khader, et al.
Annals of the Rheumatic Diseases|August 1, 1982
Studies on autoantibodies to poly (adenosine diphosphate-ribose) in SLE and other autoimmune diseasesW J Morrow, D A Isenberg, H F Parry, et al.
The Quarterly Journal of Medicine|July 1, 1993
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosusE M Hay, P A Bacon, C Gordon, et al.
Annals of the Rheumatic Diseases|August 1, 1990
Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometryV B Dhillon, M C Davies, M L Hall, et al.
Annals of the Rheumatic Diseases|December 1, 1983
The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritisW J Morrow, D J Williams, C Ferec, et al.
The Quarterly Journal of Medicine|November 1, 1988
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG)D P Symmons, J S Coppock, P A Bacon, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Clinical and Experimental Rheumatology|September 1, 1992
Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLEC Vitali, W Bencivelli, D A Isenberg, et al.
Clinical and Experimental Rheumatology|September 1, 1992
Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLEC Vitali, W Bencivelli, D A Isenberg, et al.
British Journal of Rheumatology|June 1, 1988
Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogueD A Yardumian, D A Isenberg, M Rustin, et al.
International Journal of Immunopharmacology|January 1, 1981
Cyclosporin A for the treatment of systemic lupus erythematosusD A Isenberg, M L Snaith, W J Morrow, et al.
The New England Journal of Medicine|September 25, 1980
Cyclosporin relieves arthralgia, causes angioedemaD A Isenberg, M L Snaith, A A Al-Khader, et al.
Annals of the Rheumatic Diseases|August 1, 1982
Studies on autoantibodies to poly (adenosine diphosphate-ribose) in SLE and other autoimmune diseasesW J Morrow, D A Isenberg, H F Parry, et al.
The Quarterly Journal of Medicine|July 1, 1993
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosusE M Hay, P A Bacon, C Gordon, et al.
Annals of the Rheumatic Diseases|August 1, 1990
Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometryV B Dhillon, M C Davies, M L Hall, et al.
Annals of the Rheumatic Diseases|December 1, 1983
The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritisW J Morrow, D J Williams, C Ferec, et al.
The Quarterly Journal of Medicine|November 1, 1988
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG)D P Symmons, J S Coppock, P A Bacon, et al.
Pageof 9